A Program to Increase Sickle Cell Trait Knowledge Among Parent of Young Children Identified in Newborn Screening (SCTaware)
A Comprehensive Program to Increase Sickle Cell Trait Knowledge and Awareness Among Parents of Young Children Identified in Newborn Screening
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT03984500, this NA trial focuses on Sickle Cell Trait and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2022 — Jan 2023 [monthly]
Recruiting NA
-
Feb 2021 — Jun 2022 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: None → NA
-
Aug 2019 — Apr 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Not Yet Recruiting
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
- Susan Creary
For direct contact, visit the study record on ClinicalTrials.gov .